Detalles de la búsqueda
1.
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.
Lancet Oncol
; 17(5): 651-62, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27055731
Resultados
1 -
1
de 1
1
Próxima >
>>